Eyes on New Product Development.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
Works in Journal of Ocular Pharmacology & Therapeutics, 2025, Vol 41, Issue 5
Results: 10
1
2
Durability of Treatment with a Thermomechanical Device in Meibomian Gland Dysfunction: An Observational Extension Study.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2025, v. 41, n. 5, p. 237, doi. 10.1089/jop.2025.0033
- By:
- Publication type:
- Article
3
Effect of Chemical Injury on Autophagy in Canine Corneal Stromal Fibroblasts.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2025, v. 41, n. 5, p. 266, doi. 10.1089/jop.2024.0211
- By:
- Publication type:
- Article
4
Myopia Progression Study Comparing Low-Dose (0.01%) Atropine Eye Drops with a Control Group.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2025, v. 41, n. 5, p. 244, doi. 10.1089/jop.2024.0202
- By:
- Publication type:
- Article
5
Topical Losartan in the Management of Corneal Scarring Fibrosis: Update on Dosage, Efficacy, and Potential Epithelial Toxicity.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2025, v. 41, n. 5, p. 232, doi. 10.1089/jop.2024.0200
- By:
- Publication type:
- Article
6
Medicare Part D Glaucoma Drug Prescribing Patterns by Ophthalmologists from 2018 to 2022.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2025, v. 41, n. 5, p. 259, doi. 10.1089/jop.2024.0196
- By:
- Publication type:
- Article
7
Biodistribution of Reconstituted High-Density Lipoprotein Nanoparticles for Targeted Delivery to Retinal Ganglion Cells.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2025, v. 41, n. 5, p. 281, doi. 10.1089/jop.2024.0191
- By:
- Publication type:
- Article
8
Tacrolimus 0.1% Ophthalmic Suspension: Corneal and Intraocular Penetration Study.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2025, v. 41, n. 5, p. 275, doi. 10.1089/jop.2024.0165
- By:
- Publication type:
- Article
9
Understanding Individual Intraocular Pressure Response to Treatment with Latanoprost and Timolol.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2025, v. 41, n. 5, p. 251, doi. 10.1089/jop.2024.0112
- By:
- Publication type:
- Article
10
Rosalind Franklin Society Proudly Announces the 2024 Award Recipient for Journal of Ocular Pharmacology and Therapeutics.
- Published in:
- 2025
- By:
- Publication type:
- Announcement